Wikipedia:Choosing Wisely/American Psychiatric Association

From Wikipedia, the free encyclopedia

Choosing Wisely is a health campaign which seeks to share health information with patients and health care providers.

This project shares information from the American Psychiatric Association on Wikipedia.

Articles of interest[edit]

Articles relating to American Psychiatric Association content
article traffic in March 2014* sources cited change summary
American Psychiatric Association 7702
Antipsychotic 43385 1 antipsychotics should only be prescribed after a physician has conducted an initial evaluation and made a plan for appropriate ongoing monitoring
Antipsychotic 43385 2 Antipsychotics are prescribed one at a time
Dementia 91709 3 citation added; content already covered for geriatrics society
Insomnia 93657 4 The use of antipsychotics for insomnia, while common, is not recommended as the evidence does not demonstrate a benefit and the risk of adverse effects is significant.
Antipsychotic 43385 5 Antipsychotics should not be used in children or adolescents as a first-line treatment for anything other than a psychotic disorder.
Child and adolescent psychiatry 3616 5 antipsychotic drugs as a first-line treatment for mental health problems or behavioral issues other than a psychotic disorder, which is contrary to the intended use of the drugs
  • *An arbitrary month has been chosen to present a count of pageviews. This month is neither the busiest nor slowest month, and this number seems typical for most articles in most months. Through the link anyone may check traffic in other months.

Recent changes[edit]

Review changes to all of the articles in the above table by visiting this watchlist.

References[edit]

American Psychiatric Association (September 2013), "Five Things Physicians and Patients Should Question", Choosing Wisely: an initiative of the ABIM Foundation, American Psychiatric Association, retrieved 30 December 2013, which cites

    • American Diabetes, A.; American Psychiatric, A.; American Association of Clinical Endocrinologists; North American Association for the Study of Obesity (2004). "Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes". Diabetes Care. 27 (2): 596–601. doi:10.2337/diacare.27.2.596. PMID 14747245.
    • Maglione, M.; Maher, A. R.; Hu, J.; Wang, Z.; Shanman, R.; Shekelle, P. G.; Roth, B.; Hilton, L.; Suttorp, M. J.; Ewing, B. A.; Motala, A.; Perry, T. (2011). "Off-Label Use of Atypical Antipsychotics: An Update". PMID 22132426. {{cite journal}}: Cite journal requires |journal= (help)
    • Nasrallah, H. A. (2007). "Atypical antipsychotic-induced metabolic side effects: Insights from receptor-binding profiles". Molecular Psychiatry. 13 (1): 27–35. doi:10.1038/sj.mp.4002066. PMID 17848919.
    • Correll, C. U. (2008). "Monitoring and management of antipsychotic-related metabolic and endocrine adverse events in pediatric patients". International Review of Psychiatry. 20 (2): 195–201. doi:10.1080/09540260801889179. PMID 18386212.
    • McClellan, J.; Kowatch, R.; Findling, R. L.; Work Group on Quality Issues (2007). "Practice Parameter for the Assessment and Treatment of Children and Adolescents with Bipolar Disorder". Journal of the American Academy of Child & Adolescent Psychiatry. 46 (1): 107–125. doi:10.1097/01.chi.0000242240.69678.c4. PMID 17195735.
    • Loy, J. H.; Merry, S. N.; Hetrick, S. E.; Stasiak, K. (2012). Loy, Jik H (ed.). "Atypical antipsychotics for disruptive behaviour disorders in children and youths". The Cochrane Library. 9 (9): CD008559. doi:10.1002/14651858.CD008559.pub2. PMID 22972123.
    • Zito, J. M.; Burcu, M.; Ibe, A.; Safer, D. J.; Magder, L. S. (2013). "Antipsychotic Use by Medicaid-Insured Youths: Impact of Eligibility and Psychiatric Diagnosis Across a Decade". Psychiatric Services. 64 (3): 223–229. doi:10.1176/appi.ps.201200081. PMID 23242390.

Links[edit]